Furthermore, glucose and insulin tolerance tests (GTT and ITT, respectively) revealed that Mat2a deletion protected against HFD-induced glucose intolerance and insulin resistance (Supplementary Fig. S3f, g). The gene discussed is MAT2A; the disease is Glucose intolerance.